HEADER TRANSCRIPTION REGULATOR/INHIBITOR 30-MAY-17 5W0E TITLE CREBBP BROMODOMAIN IN COMPLEX WITH CPD19 (3-(7-(DIFLUOROMETHYL)-6-(1- TITLE 2 METHYL-1H-PYRAZOL-4-YL)-3,4-DIHYDROQUINOLIN-1(2H)-YL)-N-METHYL-1- TITLE 3 (TETRAHYDRO-2H-PYRAN-4-YL)-1,4,6,7-TETRAHYDRO-5H-PYRAZOLO[4,3- TITLE 4 C]PYRIDINE-5-CARBOXAMIDE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CREB-BINDING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: BROMODOMAIN, UNP RESIDUES 1082-1197; COMPND 5 EC: 2.3.1.48; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CREBBP, CBP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CREBBP, BROMODOMAIN, SMALL MOLECULE INHIBITOR, TRANSCRIPTION KEYWDS 2 REGULATOR-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.M.MURRAY REVDAT 2 04-OCT-23 5W0E 1 REMARK REVDAT 1 21-FEB-18 5W0E 0 JRNL AUTH S.M.BRONNER,J.MURRAY,F.A.ROMERO,K.W.LAI,V.TSUI,P.CYR, JRNL AUTH 2 M.H.BERESINI,G.DE LEON BOENIG,Z.CHEN,E.F.CHOO,K.R.CLARK, JRNL AUTH 3 T.D.CRAWFORD,H.JAYARAM,S.KAUFMAN,R.LI,Y.LI,J.LIAO,X.LIANG, JRNL AUTH 4 W.LIU,J.LY,J.MAHER,J.WAI,F.WANG,A.ZHENG,X.ZHU,S.MAGNUSON JRNL TITL A UNIQUE APPROACH TO DESIGN POTENT AND SELECTIVE CYCLIC JRNL TITL 2 ADENOSINE MONOPHOSPHATE RESPONSE ELEMENT BINDING PROTEIN, JRNL TITL 3 BINDING PROTEIN (CBP) INHIBITORS. JRNL REF J. MED. CHEM. V. 60 10151 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 29155580 JRNL DOI 10.1021/ACS.JMEDCHEM.7B01372 REMARK 2 REMARK 2 RESOLUTION. 1.41 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.41 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.34 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 25617 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1298 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 26.3431 - 2.9320 0.93 2761 157 0.2214 0.2597 REMARK 3 2 2.9320 - 2.3277 0.98 2776 127 0.2316 0.2316 REMARK 3 3 2.3277 - 2.0336 0.98 2746 140 0.2158 0.2687 REMARK 3 4 2.0336 - 1.8477 0.97 2708 146 0.2213 0.2394 REMARK 3 5 1.8477 - 1.7153 0.98 2724 144 0.2276 0.2558 REMARK 3 6 1.7153 - 1.6142 0.98 2711 137 0.2360 0.2948 REMARK 3 7 1.6142 - 1.5333 0.98 2673 148 0.2516 0.2757 REMARK 3 8 1.5333 - 1.4666 0.97 2657 157 0.2670 0.3111 REMARK 3 9 1.4666 - 1.4101 0.93 2563 142 0.2931 0.3247 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.62 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 1054 REMARK 3 ANGLE : 0.852 1438 REMARK 3 CHIRALITY : 0.075 145 REMARK 3 PLANARITY : 0.006 208 REMARK 3 DIHEDRAL : 16.368 433 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -11.6969 2.9930 -6.2217 REMARK 3 T TENSOR REMARK 3 T11: 0.1079 T22: 0.1194 REMARK 3 T33: 0.1357 T12: -0.0059 REMARK 3 T13: 0.0151 T23: -0.0141 REMARK 3 L TENSOR REMARK 3 L11: 1.3986 L22: 1.5748 REMARK 3 L33: 2.0659 L12: 0.0496 REMARK 3 L13: 0.4937 L23: 0.2196 REMARK 3 S TENSOR REMARK 3 S11: 0.0201 S12: 0.0768 S13: -0.1116 REMARK 3 S21: -0.0241 S22: 0.0411 S23: -0.0160 REMARK 3 S31: 0.0882 S32: -0.0234 S33: -0.0003 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5W0E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JUN-17. REMARK 100 THE DEPOSITION ID IS D_1000228206. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-SEP-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34991 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 26.339 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.4 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.57 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.57500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5I8B REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M MGCL2, 0.1M BIS-TRIS PH6.5, 22% REMARK 280 PEG3350, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 16.90750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.90950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.69300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.90950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 16.90750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 24.69300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1050 REMARK 465 HIS A 1051 REMARK 465 HIS A 1052 REMARK 465 HIS A 1053 REMARK 465 HIS A 1054 REMARK 465 HIS A 1055 REMARK 465 HIS A 1056 REMARK 465 GLY A 1057 REMARK 465 SER A 1058 REMARK 465 LEU A 1059 REMARK 465 VAL A 1060 REMARK 465 PRO A 1061 REMARK 465 ARG A 1062 REMARK 465 GLY A 1063 REMARK 465 SER A 1064 REMARK 465 MET A 1065 REMARK 465 ASP A 1066 REMARK 465 TYR A 1067 REMARK 465 LYS A 1068 REMARK 465 ASP A 1069 REMARK 465 ASP A 1070 REMARK 465 ASP A 1071 REMARK 465 ASP A 1072 REMARK 465 LYS A 1073 REMARK 465 GLU A 1074 REMARK 465 ASN A 1075 REMARK 465 LEU A 1076 REMARK 465 TYR A 1077 REMARK 465 PHE A 1078 REMARK 465 GLN A 1079 REMARK 465 GLY A 1080 REMARK 465 SER A 1081 REMARK 465 LYS A 1082 REMARK 465 GLY A 1197 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A1122 66.67 -119.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1431 DISTANCE = 5.90 ANGSTROMS REMARK 525 HOH A1432 DISTANCE = 5.92 ANGSTROMS REMARK 525 HOH A1433 DISTANCE = 6.49 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9U4 A 1201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5VZS RELATED DB: PDB DBREF 5W0E A 1082 1197 UNP Q92793 CBP_HUMAN 1082 1197 SEQADV 5W0E MET A 1050 UNP Q92793 INITIATING METHIONINE SEQADV 5W0E HIS A 1051 UNP Q92793 EXPRESSION TAG SEQADV 5W0E HIS A 1052 UNP Q92793 EXPRESSION TAG SEQADV 5W0E HIS A 1053 UNP Q92793 EXPRESSION TAG SEQADV 5W0E HIS A 1054 UNP Q92793 EXPRESSION TAG SEQADV 5W0E HIS A 1055 UNP Q92793 EXPRESSION TAG SEQADV 5W0E HIS A 1056 UNP Q92793 EXPRESSION TAG SEQADV 5W0E GLY A 1057 UNP Q92793 EXPRESSION TAG SEQADV 5W0E SER A 1058 UNP Q92793 EXPRESSION TAG SEQADV 5W0E LEU A 1059 UNP Q92793 EXPRESSION TAG SEQADV 5W0E VAL A 1060 UNP Q92793 EXPRESSION TAG SEQADV 5W0E PRO A 1061 UNP Q92793 EXPRESSION TAG SEQADV 5W0E ARG A 1062 UNP Q92793 EXPRESSION TAG SEQADV 5W0E GLY A 1063 UNP Q92793 EXPRESSION TAG SEQADV 5W0E SER A 1064 UNP Q92793 EXPRESSION TAG SEQADV 5W0E MET A 1065 UNP Q92793 EXPRESSION TAG SEQADV 5W0E ASP A 1066 UNP Q92793 EXPRESSION TAG SEQADV 5W0E TYR A 1067 UNP Q92793 EXPRESSION TAG SEQADV 5W0E LYS A 1068 UNP Q92793 EXPRESSION TAG SEQADV 5W0E ASP A 1069 UNP Q92793 EXPRESSION TAG SEQADV 5W0E ASP A 1070 UNP Q92793 EXPRESSION TAG SEQADV 5W0E ASP A 1071 UNP Q92793 EXPRESSION TAG SEQADV 5W0E ASP A 1072 UNP Q92793 EXPRESSION TAG SEQADV 5W0E LYS A 1073 UNP Q92793 EXPRESSION TAG SEQADV 5W0E GLU A 1074 UNP Q92793 EXPRESSION TAG SEQADV 5W0E ASN A 1075 UNP Q92793 EXPRESSION TAG SEQADV 5W0E LEU A 1076 UNP Q92793 EXPRESSION TAG SEQADV 5W0E TYR A 1077 UNP Q92793 EXPRESSION TAG SEQADV 5W0E PHE A 1078 UNP Q92793 EXPRESSION TAG SEQADV 5W0E GLN A 1079 UNP Q92793 EXPRESSION TAG SEQADV 5W0E GLY A 1080 UNP Q92793 EXPRESSION TAG SEQADV 5W0E SER A 1081 UNP Q92793 EXPRESSION TAG SEQRES 1 A 148 MET HIS HIS HIS HIS HIS HIS GLY SER LEU VAL PRO ARG SEQRES 2 A 148 GLY SER MET ASP TYR LYS ASP ASP ASP ASP LYS GLU ASN SEQRES 3 A 148 LEU TYR PHE GLN GLY SER LYS LYS ILE PHE LYS PRO GLU SEQRES 4 A 148 GLU LEU ARG GLN ALA LEU MET PRO THR LEU GLU ALA LEU SEQRES 5 A 148 TYR ARG GLN ASP PRO GLU SER LEU PRO PHE ARG GLN PRO SEQRES 6 A 148 VAL ASP PRO GLN LEU LEU GLY ILE PRO ASP TYR PHE ASP SEQRES 7 A 148 ILE VAL LYS ASN PRO MET ASP LEU SER THR ILE LYS ARG SEQRES 8 A 148 LYS LEU ASP THR GLY GLN TYR GLN GLU PRO TRP GLN TYR SEQRES 9 A 148 VAL ASP ASP VAL TRP LEU MET PHE ASN ASN ALA TRP LEU SEQRES 10 A 148 TYR ASN ARG LYS THR SER ARG VAL TYR LYS PHE CYS SER SEQRES 11 A 148 LYS LEU ALA GLU VAL PHE GLU GLN GLU ILE ASP PRO VAL SEQRES 12 A 148 MET GLN SER LEU GLY HET 9U4 A1201 38 HETNAM 9U4 3-[7-(DIFLUOROMETHYL)-6-(1-METHYL-1H-PYRAZOL-4-YL)-3,4- HETNAM 2 9U4 DIHYDROQUINOLIN-1(2H)-YL]-N-METHYL-1-(OXAN-4-YL)-1,4, HETNAM 3 9U4 6,7-TETRAHYDRO-5H-PYRAZOLO[4,3-C]PYRIDINE-5- HETNAM 4 9U4 CARBOXAMIDE FORMUL 2 9U4 C27 H33 F2 N7 O2 FORMUL 3 HOH *133(H2 O) HELIX 1 AA1 LYS A 1086 ARG A 1103 1 18 HELIX 2 AA2 SER A 1108 ARG A 1112 5 5 HELIX 3 AA3 ASP A 1116 GLY A 1121 1 6 HELIX 4 AA4 ASP A 1124 VAL A 1129 1 6 HELIX 5 AA5 ASP A 1134 THR A 1144 1 11 HELIX 6 AA6 GLU A 1149 ASN A 1168 1 20 HELIX 7 AA7 SER A 1172 LEU A 1196 1 25 CISPEP 1 ASP A 1105 PRO A 1106 0 5.84 SITE 1 AC1 14 PRO A1106 LEU A1109 PRO A1110 PHE A1111 SITE 2 AC1 14 VAL A1115 ILE A1122 ASN A1168 ARG A1173 SITE 3 AC1 14 VAL A1174 PHE A1177 GLU A1186 HOH A1304 SITE 4 AC1 14 HOH A1326 HOH A1381 CRYST1 33.815 49.386 79.819 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029573 0.000000 0.000000 0.00000 SCALE2 0.000000 0.020249 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012528 0.00000